Saksoft Ltd gets rectified NCLT order for Augmento Labs merger
- Saksoft Ltd received a rectified NCLT order on October 1, 2026, for the merger of Augmento Labs Private Limited.
- Corrections included fixing the Appointed Date to April 1, 2026, and clarifying party designations.
- The Tribunal rejected requests to add new factual details to the original September 16, 2026, order.
- No new shares will be issued as Augmento Labs is a wholly owned subsidiary of Saksoft.

*this image is generated using AI for illustrative purposes only.
Saksoft Limited received a rectified order from the National Company Law Tribunal (NCLT), Chennai Bench, on October 1, 2026, regarding the amalgamation of its wholly owned subsidiary, Augmento Labs Private Limited.
The rectification addresses specific typographical and factual errors in the original order dated September 16, 2026, which sanctioned the Scheme of Amalgamation. The corrections ensure the legal documentation accurately reflects the terms of the merger between the transferor and transferee companies.
Nature of Rectifications
The NCLT Division Bench, comprising Sanjiv Jain (Judicial) and Venkataraman Subramaniam (Technical), allowed several corrections under Rule 154 of the NCLT Rules, 2016. These rules permit the correction of clerical or arithmetical mistakes arising from accidental slips or omissions.
Key changes include:
- Clarifying Saksoft Limited as the "Transferee Company" rather than "petitioner 2 company."
- Correcting the reference to the Scheme from "Annexure 18" to "Annexure - A1."
- Updating the date of filing the second motion petition from December 26, 2025, to December 16, 2025.
- Rectifying the Appointed Date reference from April 1, 2025, to April 1, 2026, as specified in Clause 1.1.3 of the Scheme.
- Adjusting paragraph numbering where sections were erroneously repeated or missed.
Rejected Applications
The Tribunal declined certain requests for additions to the order, stating that Rule 154 does not allow for substantive additions. Specifically, the Tribunal refused to insert details regarding notices sent to the Software Technology Parks of India (STPI) and GST authorities, and declined to add a paragraph concerning the Regional Director's report observations on dispensing with shareholder meetings.
Additionally, the request to change the date of filing for application CA(CAA)/73(CHE)/2025 was rejected because the date in the original order reflected the e-filing date, which is legally valid.
Merger Details
The Scheme provides for the amalgamation of Augmento Labs Private Limited into Saksoft Limited. As Augmento Labs is a wholly owned subsidiary, no new shares will be issued by Saksoft Limited in lieu of the shares held in Augmento Labs. The shares held by Saksoft in Augmento Labs will stand cancelled automatically upon the Scheme coming into effect.
| Detail | Information |
|---|---|
| Transferor Company | Augmento Labs Private Limited |
| Transferee Company | Saksoft Limited |
| Appointed Date | April 1, 2026 |
| Original Order Date | September 16, 2026 |
| Rectified Order Date | October 1, 2026 |
| Tribunal | NCLT, Chennai Bench |
What the Numbers Show
The rectified order highlights the importance of precise dating in corporate mergers. The correction of the Appointed Date from April 1, 2025, to April 1, 2026, aligns the effective date with the prospective timeline approved by the Tribunal. This ensures that the accounting treatment and vesting of assets occur from the correct fiscal year start, avoiding potential discrepancies in financial reporting for FY27.
Historical Stock Returns for Saksoft
| 1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
|---|---|---|---|---|---|
| +4.51% | -0.39% | -7.46% | +0.62% | -29.57% | +62.99% |
How will the corrected Appointed Date of April 1, 2026, impact Saksoft's consolidated financial statements for FY27?
What operational synergies does Saksoft anticipate realizing from the full integration of Augmento Labs' AI capabilities?
Will the rectified order accelerate the timeline for the final transfer of assets and liabilities from Augmento Labs?

































